Professional
Added to YB: 2024-11-12
Pitch date: 2024-09-30
SDZ.SW [bullish]
Sandoz Group AG
+66.39%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Sandoz Group AG develops, manufactures, and markets generic pharmaceuticals and biosimilars worldwide.
Market Cap
CHF 19.7B
Pitch Price
CHF 34.58
Price Target
N/A
Dividend
1.12%
EV/EBITDA
33.49
P/E
-2.5K
EV/Sales
2.32
Sector
Pharmaceuticals
Category
growth
Show full summary:
Artisan Global Discovery Fund New Position: Sandoz Group AG
SDZ.SW (new position): Global leader in generics & biosimilars, serving 100+ markets & 500M+ people. First to introduce oral penicillin (1951) & biosimilar (HGH). Key player in antibiotics. Set to benefit from biosimilar industry growth, improving growth profile & profitability due to higher margins.
Read full article (1 min)